Biohaven Pharmaceutical Holding - 48 Year Dividend History | BHVN
Historical dividend payout and yield for Biohaven Pharmaceutical Holding (BHVN) since 1971. The current TTM dividend payout for Biohaven Pharmaceutical Holding (BHVN) as of June 14, 2019 is $0.00. The current dividend yield for Biohaven Pharmaceutical Holding as of June 14, 2019 is 0.00%.
||Medical - Biomedical and Genetics
Biohaven Pharmaceutical Holding Company Ltd. is a biopharmaceutical company. It focuses on the identification and development of orphan neurologic indications and other neurological pathways. The company's pipeline includes BHV-0223, which is a formulation of a glutamate-modulating agent; BHV-4157, which is a new chemical entity that modulates glutamate and BHV-5000, which is an in-licensed investigational agent of the Company targeting N-Methyl-D-Aspartate receptor antagonism which are in clinical trial stage. Biohaven Pharmaceutical Holding Company Ltd. is based in NEW HAVEN, United States.